Understand the role of surgery, chemotherapy, and precision cancer medicines in the treatment of Ovarian Cancer.

Understand the symptoms, risk factors, diagnosis, tests and the role of screening and early detection of ovarian cancer.

The PARP inhibitor Zejula is a precision cancer medicine that delays ovarian cancer progression and prolongs survival.

Ovarian cancer symptoms, risk factors, and treatment

PARPs and Avastin delay progression when used as maintenance therapy for certain individuals with ovarian cancer.

Answers to frequently asked questions about CA 125.

2019 saw the greatest changes in the management of ovarian cancer in 20 years - learn more.

Interleukin-2 Plus Retinoic Acid May Improve Outcomes for Recurrent Ovarian Cancer